Proteomic study in the rat hippocampus as a measure of human alzheimer’s disease

Koomesh

Volumn 16, Issue 4, 2015, Pages 611-620

  Ghamari, Esra ^a   Zali, Hakimeh ^b   Tavirani, Mostafa Rezaie ^b   Takalu, Saeed Hesami ^c   Goshadrou, Fatemeh ^d   Ahmadi, Nayebali ^b   Zamaheni, Sara ^e   Rashidy Pour, Ali ^f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer disease; Amyloid beta peptides; Clustering analysis; Proteomics

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS POTENTIAL; HUMAN; MASS SPECTROMETRY; METABOLIC REGULATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; STATISTICAL ANALYSIS; STRUCTURAL BIOINFORMATICS; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 84931315833     PISSN: 16087046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis mon 2010; 56: 484-546.
2. Barrow CJ, Small DH. Abeta Peptide and Alzheimer's Disease: Springer; 2007.
3. Kidd PM. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern Med Rev 2008; 13: 85.
4. Association As. 2008 Alzheimer's disease facts and figures. Alzheimer's & dementia: the journal of the Alzheimer's Association 2008; 4: 110.
5. Butterfield DA, Reed T, Newman SF, Sultana R. Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 2007; 43: 658-677.
6. Bekris LM, Yu CE, Bird TD, Tsuang DW. Review article: genetics of Alzheimer disease. J Geriatr Psychiatry Neurol 2010; 23: 213-227.
7. Picq JL. Aging affects executive functions and memory in mouse lemur primates. Exp Gerontol 2007; 42: 223-232.
8. Sowell RA, Owen JB, Butterfield DA. Proteomics in animal models of Alzheimer's and Parkinson's diseases. Ageing Res Rev 2009; 8: 1-17.
9. Caudle WM, Pan S, Shi M, Quinn T, Hoekstra J, Beyer RP, et al. Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease. Protemics Clin Appl 2008; 2: 1484-1497.
10. Saraceno C, Musardo S, Marcello E, Pelucchi S, Luca MD. Modeling Alzheimer’s disease: from past to future. Front Pharmacol 2013; 4: 77.
11. Benedikz E, Kloskowska E, Winblad B. The rat as an animal model of Alzheimer's disease. J Cell Mol Med 2009; 13: 1034-1042.
12. Laurijssens B, Aujard F, Rahman A. Animal models of Alzheimer's disease and drug development. Drug Discovery Today: Technologies 2013; 10: e319-e27.
13. Duyckaerts C, Potier MC, Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115: 5-38.
14. Hoseini OSM, Nobakht M, Mortazavi P, Esmailzadeh B, Rahbar Rooshandel N, Omidzahir SH. Study of histopathological lesions in CA1 of the hippocampus after injection of beta-amyloid in a rat model of alzheimer’s disease. J Babol Unive Med Sci 2012; 14: 90-96.
15. Shi X, Lu X, Zhan L, Liu L, Sun M, Gong X, et al. Rat hippocampal proteomic alterations following intrahippocampal injection of amyloid beta peptide (1–40). Neurosci Lett 2011; 500: 87-91.
16. Zali H, Rezaei Tavirani M, Pakzad I. Proteomic study of rat hippocampus in aqua extracttreatment of lavandula aqua extract. J Ilam Univ Med Sci 2013; 20: 22-31.(Persian).
17. Silva PN, Furuya TK, Braga IL, Rasmussen LT, Labio RW, Bertolucci PH, et al. Analysis of HSPA8 and HSPA9 mRNA expression and promoter methylation in the brain and blood of Alzheimer's disease patients. J Alzheimer's Dis 2014; 38: 165-170.
18. Xu PT, Li YJ, Qin XJ, Scherzer CR, Xu H, Schmechel DE, et al. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis 2006; 21: 256-275.
19. Zahid S, Oellerich M, Asif AR, Ahmed N. Differential expression of proteins in brain regions of Alzheimer’s disease patients. Neurochem Res 2014; 39: 208-215.
20. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2001; 2: 492-501.
21. Liu HY, Liao PC, Chuang KT, Kao MC. Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy. J Biomed Sci 2011; 18: 1-17.
22. Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, Masliah E. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer’s disease. Brain Res 2001; 914: 48-56.
23. Mizukami K, Abrahamson EE, Mi Z, Ishikawa M, Watanabe K, Kinoshita S, et al. Immunohistochemical analysis of ubiquilin‐1 in the human hippocampus: Association with neurofibrillary tangle pathology. Neuropathology 2014; 34: 11-18.
24. Kim SH, Fountoulakis M, Cairns NJ, Lubec G. Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome. Biochem Biophys Res Commun 2002; 296: 970-975.
25. Stolmeier D, Thangavel R, Anantharam P, Khan MM, Kempuraj D, Zaheer A. Glia maturation factor expression in hippocampus of human Alzheimer’s disease. Neurochem Res 2013; 38: 1580-1589.
26. Hsu WC, Wang HK, Lee LC, Fung HC, Lin JC, Hsu HP, et al. Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer’s disease. J Neural Trans 2008; 115: 1537-1543.
27. Jin LW, Masliah E, Iimoto D, Deteresa R, Mallory M, Sundsmo M, et al. Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease. Neurobiol Aging 1996; 17: 331-341.
28. Shibata N, Nagata T, Shinagawa S, Ohnuma T, Shimazaki H, Komatsu M, et al. Genetic association between APOA1 and APOD polymorphisms and Alzheimer’s disease in a Japanese population. J Neural Transm 2013; 120: 1599-1603.
29. Nakamura Y, Takeda M, Yoshimi K, Hattori H, Hariguchi S, Kitajima S, Hashimoto S, Nishimura T. Involvement of clathrin light chains in the pathology of Alzheimer's disease. Acta Neuropathol 1994; 87: 23-31.
30. Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 2006; 22: 223-232.
31. Salomonis N, Hanspers K, Zambon AC, Vranizan K, Lawlor SC, Dahlquist KD, Doniger SW, Stuart J, Conklin BR, Pico AR. GenMAPP 2: new features and resources for pathway analysis. BMC Bioinformatics 2007; 8: 217.
32. Summer-Kutmon M. Managing Biological Data in Pathways and Networks. Netherlands: Maastricht University; 2014.
33. Curtain CC AF, Volitakis I, Cherny RA, Norton RS, Beyreuther K, et al. Structural Neuroimaging: Early Diagnosis and Staging of Alzheimer's disease in Alzheimer's disease and related disorders: Etiology, Pathogenesis and Therapeutics. West Sussex, England,: John Wiley & Sons, Ltd; 1999.
34. Savioz A, Leuba G, Vallet PG, Walzer C. Contribution of neural networks to Alzheimer disease's progression. Brain Res Bull 2009; 80: 309-314.
35. Law A, Gauthier S, Quirion R. Say NO to Alzheimer’s disease: the putative links between nitric oxide and dementia of the Alzheimer’s type. Brain Res Rev 2001; 35: 73-96.
36. Butterfield DA, Boyd-Kimball D, Castegna A. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J Neurochem 2003; 86: 1313-1327.
37. Noorbakhsh FR S. Heat shock proteins (HSPs). Tehran: Andishehsara; 2012.
38. Lu RC, Tan MS, Wang H, Xie AM, Yu JT, Tan L. Heat shock protein 70 in Alzheimer’s disease. Bio Med Res Internat 2014; 2014: 8.
39. Weng WC, Lee WT, Hsu WM, Chang BE, Lee H. Role of glucose-regulated Protein 78 in embryonic development and neurological disorders. J Formosan Med Assoc 2011; 110: 428-437.
40. Di Domenico F, Sultana R, Tiu GF, Scheff NN, Perluigi M, Cini C, Butterfield DA. Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res 2010; 1333: 72-81.
41. Plantier M, Der Terrossian E, Represa A. β-Actin immunoreactivity in rat microglial cells: developmental pattern and participation in microglial reaction after kainate injury. Neurosci Lett 1998; 247: 49-52.
42. Ghadami SA. Amyloid and perion. Isfahan: Behta Pazhouhesh 2011. (Persian).